DE68916362D1 - Immunologische Reagenz-Zusammensetzung und deren Verwendung zur Bestimmung von chlamydialen oder gonokokkalen Antigenen. - Google Patents

Immunologische Reagenz-Zusammensetzung und deren Verwendung zur Bestimmung von chlamydialen oder gonokokkalen Antigenen.

Info

Publication number
DE68916362D1
DE68916362D1 DE68916362T DE68916362T DE68916362D1 DE 68916362 D1 DE68916362 D1 DE 68916362D1 DE 68916362 T DE68916362 T DE 68916362T DE 68916362 T DE68916362 T DE 68916362T DE 68916362 D1 DE68916362 D1 DE 68916362D1
Authority
DE
Germany
Prior art keywords
chlamydial
determination
reagent composition
immunological reagent
gonococcal antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68916362T
Other languages
English (en)
Other versions
DE68916362T2 (de
Inventor
Allan David Pronovost
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Clinical Diagnostics Inc
Original Assignee
Eastman Kodak Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22970418&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE68916362(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eastman Kodak Co filed Critical Eastman Kodak Co
Application granted granted Critical
Publication of DE68916362D1 publication Critical patent/DE68916362D1/de
Publication of DE68916362T2 publication Critical patent/DE68916362T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56927—Chlamydia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/571—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE68916362T 1988-10-07 1989-09-29 Immunologische Reagenz-Zusammensetzung und deren Verwendung zur Bestimmung von chlamydialen oder gonokokkalen Antigenen. Expired - Fee Related DE68916362T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/255,925 US5047326A (en) 1988-10-07 1988-10-07 Immunmological reagent composition and its use in the determination of chlamydial or gonococcal antigens

Publications (2)

Publication Number Publication Date
DE68916362D1 true DE68916362D1 (de) 1994-07-28
DE68916362T2 DE68916362T2 (de) 1995-02-16

Family

ID=22970418

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68916362T Expired - Fee Related DE68916362T2 (de) 1988-10-07 1989-09-29 Immunologische Reagenz-Zusammensetzung und deren Verwendung zur Bestimmung von chlamydialen oder gonokokkalen Antigenen.

Country Status (4)

Country Link
US (1) US5047326A (de)
EP (1) EP0363091B1 (de)
JP (1) JPH07109420B2 (de)
DE (1) DE68916362T2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807752A (en) * 1992-09-11 1998-09-15 Boehringer Mannheim Corporation Assay using an unblocked solid phase with immobilized analyte binding partner
US5415994A (en) * 1993-08-02 1995-05-16 Quidel Corporation Lateral flow medical diagnostic assay device with sample extraction means
GB9417864D0 (en) * 1994-09-06 1994-10-26 Sinvent As Cell separation
GB9515855D0 (en) * 1995-08-02 1995-10-04 Centocor U K Limited A specimen dilution indicator system for use in clinical diagnostic assays
US5773234A (en) * 1995-08-07 1998-06-30 Quidel Corporation Method and device for chlamydia detection
AU6720096A (en) 1995-08-09 1997-03-05 Quidel Corporation Test strip and method for one step lateral flow assay
US6150094A (en) * 1996-05-23 2000-11-21 Qiagen Gmbh Use of an osmolyte for reducing or abolishing no-covalent interactions of biological molecules to inert surfaces
DE69610410T2 (de) * 1996-05-23 2001-05-10 Qiagen Gmbh Verwendung eines Osmolyten zur Verringerung oder Aufhebung von nichtkovalenten Bindungen biologischer Moleküle an inerten Oberflächen
US6838552B1 (en) * 1997-08-14 2005-01-04 Vanderbilt University Diagnosis and management of infection caused by Chlamydia
US20060073531A1 (en) * 1996-08-14 2006-04-06 Vanderbilt University Anti-chlamydial antibodies and uses thereof
US6284194B1 (en) 1998-03-11 2001-09-04 Albert E. Chu Analytical assay device and methods using surfactant treated membranes to increase assay sensitivity
WO2005050209A1 (en) * 2003-11-20 2005-06-02 Biosensor Applications Sweden (Publ) Mixture of at least two different antibodies specific for predetermined antigens and use of the mixture
US20080145940A1 (en) * 2006-12-18 2008-06-19 3M Innovative Properties Company Chemical indicator test strip
US20080145948A1 (en) * 2006-12-18 2008-06-19 3M Innovative Properties Company Chemical indicator test strip
WO2012012748A2 (en) * 2010-07-23 2012-01-26 Luminex Corporation Co-coupling to control reactivity of reagents in immunoassays
CN109633161B (zh) * 2018-11-22 2022-02-01 深圳上泰生物工程有限公司 一种基于胶乳增强免疫比浊法的降钙素原检测试剂盒

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0047472B1 (de) * 1980-09-02 1985-04-24 Fuji Photo Film Co., Ltd. Verfahren zur immunochemischen Bestimmung von Spurenteilen
US4497899A (en) * 1982-04-12 1985-02-05 Abbott Laboratories Immunoassay for Chlamydia trachomatis antigens
US4497900A (en) * 1982-04-12 1985-02-05 Abbott Laboratories Immunoassay for Neisseria gonorrhoeae antigens
JPS58182862A (ja) * 1982-04-21 1983-10-25 Hitachi Ltd Ｃｍｏｓ集積回路装置
GB8317855D0 (en) * 1983-06-30 1983-08-03 Iq Bio Ltd Biochemical detection method
AU6839587A (en) * 1985-12-10 1987-06-30 Murex Corp. Particle-bound binding component immunoassay
WO1987006620A1 (en) * 1986-04-29 1987-11-05 Murex Corporation Diagnostic kit for sexually transmitted diseases
EP0264036B1 (de) * 1986-10-16 1993-06-30 Abbott Laboratories Analytisches Gerät und Verfahren zum Nachweis von Chlamydia Trachomatis und Neisseria Gonorrhoeae
EP0280560B1 (de) * 1987-02-27 1994-05-11 EASTMAN KODAK COMPANY (a New Jersey corporation) Mit Nieder-pI-Protein beschichtete Membranstruktur und Verfahren zu ihrer Herstellung und Verwendung
US4812414A (en) * 1987-09-18 1989-03-14 Eastman Kodak Company Immunoreactive reagent particles having tracer, receptor molecules and protein of pI less than 6
SE460803B (sv) * 1987-04-15 1989-11-20 Pharmacia Ab Saett att immunkemiskt bestaemma klamydia-infektion
DE3871799D1 (de) * 1987-07-14 1992-07-09 Univ Manchester Verfahren zur diagnose von infektionen, bei welchem lipopolyscaccharidantigene bestimmt werden.

Also Published As

Publication number Publication date
JPH07109420B2 (ja) 1995-11-22
JPH02156158A (ja) 1990-06-15
EP0363091B1 (de) 1994-06-22
US5047326A (en) 1991-09-10
DE68916362T2 (de) 1995-02-16
EP0363091A3 (en) 1990-09-12
EP0363091A2 (de) 1990-04-11

Similar Documents

Publication Publication Date Title
DE68916362T2 (de) Immunologische Reagenz-Zusammensetzung und deren Verwendung zur Bestimmung von chlamydialen oder gonokokkalen Antigenen.
DE3781170T2 (de) Hydrolysierbare fluoreszierende substrate und deren verwendung zur analytischen bestimmung.
DE69126664D1 (de) Bestimmung von analyten in biologischen flüssigkeiten in gegenwart von störenden substanzen
ATE16820T1 (de) Testelement zur bestimmung von glukose in hoher konzentration.
DE69022819T2 (de) Verbindungen und Reagenzien zur Bestimmung von Retikulozyten.
DE68912218T2 (de) Zusammensetzung und Verfahren zur Bestimmung spezifischer Gravitation von wässerigen Flüssigkeiten.
DE3784471T2 (de) Bestimmung und kontrolle von sulfatreduzierenden bakterien.
DE68924118T2 (de) Hoch-pH-Extraktionszusammensetzung und deren Verwendung zur Bestimmung von Antigenen aus Chlamydia, Gonokokken oder Herpes.
DE3863285D1 (de) Verfahren und reagenz zur bestimmung von persaeuren.
DE3788148D1 (de) Monoklonale Antikörper und deren Verwendung.
DE3874387D1 (de) Immunologische methoden und materialien zur bestimmung von tumor assoziierten antigenen.
DE3787706D1 (de) Verfahren zur quantitativen Bestimmung der Antigene und Antikörper.
DE68909995D1 (de) Reagenz zur Bestimmung von Kreatinkinase und Messverfahren dafür.
DE59408245D1 (de) Rollenträger zur Bestimmung von immanenten Kräften
DE3778085D1 (de) Bindungstest und testreagens.
DE68919982D1 (de) Ein Sulfydril enthaltendes Reduktionsmittel enthaltende stabilisierte Extraktionszusammensetzung und deren Verwendung zur Bestimmung von Chlamydia und Gonokokken.
ES2046187T3 (es) Anticuerpos para uso en la determinacion de la glucoalbumina humana.
DE3580780D1 (de) Reagenzzusammensetzung, trockenes element und verfahren zur bestimmung des gesamt-bilirubins.
DE68907377D1 (de) Agens und geraet zur bestimmung von antigenen oder antikoerpern.
DE3674628D1 (de) Immunochemisches verfahren, analytische zusammensetzung und element zur bestimmung von kreatin-kinase-mb.
DE3778471D1 (de) Testreagens zur bestimmung von amylase.
FI893333A (fi) Menetelmä ja reagenssi vasta-aineiden määrittämiseksi
KR880002048A (ko) 알킬니트론을 함유하는 콘트라스트 증강층 조성물 및 이의 용도
ATE75261T1 (de) Testreagens zur bestimmung von amylase.
DE58902573D1 (de) Mikrotitrationsplatte und verfahren zur quantitativen bestimmung des zustandes oder von zustandsaenderungen von inhomogenen proben.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: JOHNSON & JOHNSON CLINICAL DIAGNOSTICS, INC., ROCH

8328 Change in the person/name/address of the agent

Free format text: STREHL, SCHUEBEL-HOPF, GROENING & PARTNER, 80538 MUENCHEN

8365 Fully valid after opposition proceedings
8339 Ceased/non-payment of the annual fee